Overview

A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty

Status:
Recruiting

Trial end date:
2023-12-30

Target enrollment:

Participant gender:

Summary

Adding a single preoperative dose of gabapentin to the standard pain regimen will reduce postoperative opioid consumption within the first 72 hours in patients undergoing rhinoplasty.

Phase:

Phase 1

Details

Lead Sponsor:

Ohio State University

Treatments:

Analgesics, Opioid
Gabapentin
gamma-Aminobutyric Acid